Actinium Pharmaceuticals, Inc. Announces Launch of cialis daily canada Additional Antibody Actinium-225 Labeling Program

Print E-mail
Wednesday, 16 July 2014 11:51
NEW YORK--Actinium Pharmaceuticals, Inc . (nyse mkt:ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the how much cialis treatment of viagra fast delivery advanced cancers initiated development of cialis online 60mg an additional antibody construct labeled with actinium-225.

PV-10 Immune Mechanism Data to indian cialis Be Presented at the order cialis without prescription American Association for Cancer Research Annual Meeting

Print E-mail
Thursday, 06 March 2014 12:01
KNOXVILLE, Tenn.-- Provectus Biopharmaceuticals, Inc. (OTCQB:PVCT), a development-stage oncology and viagra online pharmacy dermatology biopharmaceutical company, announced that data will be presented by researchers from Moffitt Cancer Center in a poster presentation at the American Association for Cancer Research Annual Meeting in San Diego, California.

BioMedReports Is Exact Sciences still a buy at these prices?: As biotech investors may know, the FDA approved a new genetic...
BioMedReports CEL-SCI Expands its Global Phase III Cancer Trial in Canada; Oncothyreon Plunges On Drug Fail: Below is buy no rx viagra a look...
BioMedReports Healthcare Review: Depomed, Oncothyreon, Amgen, Skilled Healthcare, Pharmacyclics: U.S. stocks rose for a sec...
navigation supporter Seeking Alpha Certified